InRetail Perú Corp. (INREF)

InRetail Perú Corp. (INREF) Consumer Business Overview

InRetail Perú Corp. is a multi-format retailer operating primarily in Peru, encompassing food retail, pharmacies, distribution, shopping centers, and digital commerce. As a subsidiary of Intercorp Retail Inc., it leverages a diversified portfolio to serve the Peruvian consumer market, maintaining a significant presence across essential and discretionary retail segments.

What Is the Investment Thesis for INREF?

InRetail Perú Corp. presents a diversified retail investment thesis anchored by its multi-format operations predominantly in Peru. The company's strategic segmentation across Food Retail, Pharmacies, Distribution, Shopping Centers, and Digital platforms provides inherent resilience and multiple revenue streams, mitigating reliance on any single market trend. With a P/E ratio of 10.3 and a profit margin of 4.2%, the company demonstrates operational efficiency within its sector. A notable dividend yield of 4.28% suggests a commitment to shareholder returns, potentially appealing to income-focused investors. Key growth catalysts include the ongoing expansion and optimization of its digital commerce services, which can capture increasing online consumer spending, and the potential for further development within its real estate and shopping center portfolio, enhancing asset value and recurring lease income. The established Inkafarma and Mifarma pharmacy chains offer a stable, high-frequency customer base, providing a defensive element to its consumer cyclical exposure. Its position as a subsidiary of Intercorp Retail Inc. also implies potential synergies and strategic backing.

Based on FMP financials and quantitative analysis

INREF Key Highlights

• Market capitalization of $2.85B, reflecting its significant scale within the Peruvian retail sector.
• A P/E ratio of 10.3, indicating a potentially attractive valuation relative to earnings within the consumer cyclical industry.
• Profit margin of 4.2% and a gross margin of 26.2%, demonstrating operational profitability and efficient cost management across its diverse retail formats.
• A robust dividend yield of 4.28%, signaling a commitment to returning capital to shareholders and providing an income component for investors.
• Operates with 47,234 employees, underscoring its extensive operational footprint and significant contribution to employment in Peru.

Who Are INREF's Competitors?

INREF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are INREF's Key Strengths?

• Diversified multi-format retail operations across essential and discretionary segments.
• Strong market presence and brand recognition in Peru, particularly with pharmacy chains.
• Integrated distribution network supporting efficient supply chain management.
• Significant real estate portfolio generating lease income and asset value.

What Are INREF's Weaknesses?

• High employee count (47,234) could lead to significant labor costs and management complexity.
• Reliance primarily on the Peruvian market exposes the company to country-specific economic fluctuations.
• "Unknown" disclosure status for OTC trading may deter some institutional investors.
• Beta of 0.07 suggests low sensitivity to market movements, potentially indicating lower growth perception or limited liquidity.

What Could Drive INREF Stock Higher?

• Continued expansion of the digital commerce segment, potentially leading to increased online sales penetration and market share in Peru's growing e-commerce landscape.
• Strategic optimization and potential new developments within the Shopping Center segment, enhancing recurring lease income and asset value.
• Organic growth within the Food Retail and Pharmacies segments through new store openings or enhanced product offerings in underserved Peruvian regions.
• Efficiency improvements and technological upgrades in the Distribution segment, aiming to reduce operational costs and improve supply chain effectiveness.

What Are the Key Risks for INREF?

• Exposure to economic fluctuations and political instability within Peru, which could impact consumer spending and overall retail demand.
• Increased competition from domestic and international retailers, potentially leading to pricing pressures and erosion of market share across its segments.
• Regulatory changes in the retail, pharmaceutical, or real estate sectors in Peru, which could affect operational costs or business models.
• Challenges associated with operating on the OTC Other market, including limited liquidity, price volatility, and an "Unknown" disclosure status, deterring institutional investment.
• Managing a large workforce of 47,234 employees, which entails significant labor costs and potential industrial relations challenges.

What Are the Growth Opportunities for INREF?

• Expansion of Digital Commerce Services: The Digital segment, which manages and supports digital commerce, represents a significant growth avenue. With increasing internet penetration and e-commerce adoption in Peru, InRetail Perú Corp. can capture a larger share of online consumer spending. Enhancing user experience, expanding product offerings, and optimizing logistics for last-mile delivery can drive substantial revenue growth. This opportunity is ongoing, with market projections for e-commerce in Latin America showing continued double-digit growth rates annually, suggesting a large addressable market for digital expansion over the next 5-10 years.
• Further Penetration in Food Retail: InRetail Perú Corp.'s Food Retail segment, encompassing supermarkets, hypermarkets, discount stores, and cash and carry formats, has room for organic growth and market share expansion within Peru. This can be achieved through strategic store openings in underserved areas, optimizing existing store layouts for efficiency, and introducing new private-label products to enhance margins and customer loyalty. The Peruvian food retail market, while mature in some urban centers, still offers opportunities in developing regions and through catering to specific consumer niches, with ongoing growth driven by population increases and rising disposable incomes.
• Optimization and Expansion of Pharmacy Network: The Pharmacies segment, operating under the Inkafarma and Mifarma brands, provides a stable and high-frequency customer base. Growth can be driven by expanding the physical footprint of these pharmacies into new neighborhoods and smaller towns, enhancing product diversification to include more wellness and beauty items, and integrating digital health services. The demand for healthcare and personal care products remains robust and resilient to economic fluctuations, offering a consistent growth trajectory for this segment over the long term, supported by demographic shifts and health awareness.
• Development of New Shopping Centers and Real Estate: The Shopping Center segment, which leases commercial stores, and the broader real estate development business offer capital-intensive but high-return growth. Identifying strategic locations for new shopping centers or expanding existing ones can create integrated retail and entertainment hubs, attracting both tenants and consumers. This not only generates lease income but also enhances the overall ecosystem for InRetail Perú Corp.'s other retail formats. Such projects typically have a medium-to-long-term timeline (3-7 years for development and maturation) but can significantly increase asset value and recurring revenue streams.
• Supply Chain and Distribution Network Enhancement: The Distribution segment, responsible for drugs, medicines, and consumer products, can be a source of efficiency-driven growth. Investing in advanced logistics technologies, optimizing warehousing, and expanding distribution routes can reduce operational costs and improve delivery times, thereby enhancing profitability across all segments. Furthermore, a highly efficient distribution network could potentially be leveraged to offer third-party logistics services, creating an additional revenue stream. This ongoing operational improvement offers continuous benefits and competitive advantages, directly impacting gross margins and overall profitability.

What Opportunities Does INREF Have?

• Expansion of digital commerce services to capture growing online consumer spending.
• Further development and optimization of its shopping center portfolio.
• Organic growth in food retail and pharmacy segments through new locations and product diversification.
• Leveraging distribution network for third-party logistics services.

What Threats Does INREF Face?

• Intensified competition from both local and international retailers entering the Peruvian market.
• Economic downturns or political instability in Peru impacting consumer spending.
• Regulatory changes affecting retail, pharmaceutical, or real estate sectors.
• Disruption from new e-commerce players and evolving consumer purchasing habits.

What Are INREF's Competitive Advantages?

• Extensive Multi-Format Retail Network: A diversified portfolio of supermarkets, hypermarkets, pharmacies, and shopping centers provides broad market penetration and customer reach across Peru.
• Established Brand Recognition: Strong brand equity with well-known pharmacy chains like Inkafarma and Mifarma, fostering customer trust and loyalty in essential retail.
• Integrated Supply Chain: A robust distribution segment supports efficient logistics for drugs, medicines, and consumer products, enhancing operational efficiency and cost control.
• Real Estate Asset Base: Ownership and development of shopping centers and other real estate provide recurring lease income and long-term asset appreciation, creating a stable revenue component.

What Does INREF Do?

InRetail Perú Corp., established in 2011 and based in Lima, Peru, has evolved into a prominent multi-format retailer within the Peruvian market. As a subsidiary of Intercorp Retail Inc., the company strategically operates across five distinct segments: Food Retail, Pharmacies, Distribution, Shopping Center, and Digital, demonstrating a comprehensive approach to consumer engagement. The Food Retail segment forms a foundational pillar, managing a diverse portfolio of supermarkets, hypermarkets, discount stores, and cash and carry outlets, catering to various consumer purchasing behaviors and income levels. Complementing this, the Pharmacies segment, through its well-known chains Inkafarma and Mifarma, plays a critical role in the supply of drugs, medicines, and cosmetic-related products, addressing essential healthcare and personal care needs across Peru. The company's operational breadth extends to its Distribution segment, which efficiently manages the logistics and supply chain for drugs, medicines, and a wide array of consumer products, supporting both its internal retail operations and potentially external partners. Furthermore, InRetail Perú Corp. is a significant player in commercial real estate through its Shopping Center segment, which focuses on the leasing of commercial stores within its developed shopping centers, creating integrated retail and leisure destinations. In response to evolving consumer trends, the Digital segment manages, operates, and provides support for digital commerce services, enhancing accessibility and convenience for its customers. Beyond its core retail and distribution activities, the company is also actively involved in the real estate development business, indicating a long-term strategy to expand its physical footprint and asset base. With 47,234 employees, InRetail Perú Corp. maintains a substantial operational scale and market reach within Peru's consumer cyclical sector.

What Products and Services Does INREF Offer?

• Operates supermarkets, hypermarkets, discount stores, and cash and carry stores under its Food Retail segment.
• Manages the Inkafarma and Mifarma pharmacy chains, supplying drugs, medicines, and cosmetic products.
• Distributes drugs, medicines, and various consumer products across Peru.
• Leases commercial spaces within its portfolio of shopping centers.
• Provides management, operation, and support for digital commerce services.
• Engages in real estate development projects, expanding its physical asset base.
• Functions as a multi-format retailer, catering to diverse consumer needs in Peru.

How Does INREF Make Money?

• Generates revenue through direct sales of food, pharmaceuticals, and consumer goods via its retail formats.
• Earns income from leasing commercial stores within its shopping centers to various tenants.
• Receives revenue from distribution services for drugs, medicines, and consumer products.
• Monetizes digital commerce services through online sales and potentially related support functions.
• Engages in real estate development, likely generating income from property sales or long-term asset appreciation.

What Industry Does INREF Operate In?

InRetail Perú Corp. operates within the dynamic Consumer Cyclical sector, specifically positioned within the Department Stores industry, though its multi-format approach extends beyond traditional department stores to encompass essential retail. The Peruvian retail market is characterized by evolving consumer preferences, increasing urbanization, and a growing middle class, driving demand across food, pharmacy, and general merchandise categories. InRetail Perú Corp. leverages its diversified segments—Food Retail, Pharmacies, Distribution, Shopping Center, and Digital—to capture various market opportunities. Its strong presence in essential services like food and pharmaceuticals provides a degree of stability, while its shopping centers and digital platforms cater to discretionary spending and modern retail trends. The competitive landscape in Peru includes both local and international players, but InRetail Perú Corp.'s extensive physical footprint, established brand recognition through chains like Inkafarma and Mifarma, and integrated supply chain provide a significant competitive advantage. The company's strategy aligns with broader industry trends towards omnichannel retail and the development of integrated consumer ecosystems.

Who Are INREF's Key Customers?

• General consumers across various income levels for food retail and pharmacy products.
• Businesses and smaller retailers utilizing cash and carry formats for bulk purchases.
• Tenants, including national and international brands, leasing commercial space in shopping centers.
• Online shoppers seeking convenience for a wide range of products via digital platforms.
• Healthcare providers and individual consumers for pharmaceutical and wellness products.

Company Profile

InRetail Perú Corp. operates in the Department Stores industry within the Consumer Cyclical sector. It is headquartered in Panama, PE. The company is led by CEO Juan Carlos Vallejo Blanco. INREF has traded publicly since 2019.

How InRetail Perú Corp. Is Valued

InRetail Perú Corp. carries a market capitalization of $2.85B, placing it in the mid-cap category. Relative to its peer group, INREF's quantitative score of 51/100 is roughly in line with the peer average of 47/100.

ROE 15%Key Financial Metrics

Return on equity for InRetail Perú Corp. stands at 14.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.1%, showing how much profit it generates from its asset base. INREF trades at a trailing price-to-earnings ratio of 10.30, below the Consumer Cyclical sector average of ~39x. Its free cash flow yield is 23.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.92 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 9.7%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 7/9Financial Health

InRetail Perú Corp.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 1.83 places it in the grey zone, a middle ground that warrants monitoring.

FY2026 estForward Outlook

Wall Street analysts project InRetail Perú Corp. revenue of about $24.30B for fiscal 2026, with EPS near $9.38. The estimate reflects 3 contributing analysts.

INREF Financials

INREF Latest News

INREF Analyst Consensus

INREF MoonshotScore

Common Questions About INREF (Consumer Cyclical)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources